To assess antiproliferativeeffects in a panel of cancer cell lines, 46 was testedin DLBCL cell lines, harboring EZH2-activating mutations, along withother cancer cell types characterized by EZH2 overexpression. This evidence concerns the gene EZH2 and cancer.